Cargando…
An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics
Since a novel coronavirus pneumonia outbreak in late December 2019, coronavirus disease -19 (COVID-19) epidemic has gradually spread worldwide, becoming a major public health event. No specific antivirals are currently available for COVID-19 caused by severe acute respiratory syndrome coronavirus 2...
Autores principales: | Wang, Dongyuan, Li, Zigang, Liu, Yihui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357519/ https://www.ncbi.nlm.nih.gov/pubmed/32684351 http://dx.doi.org/10.1016/j.jiph.2020.07.004 |
Ejemplares similares
-
Overview of therapeutic drug research for COVID-19 in China
por: Li, Heng, et al.
Publicado: (2020) -
A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
por: Kumari, Monika, et al.
Publicado: (2022) -
Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview
por: Gholizadeh, Omid, et al.
Publicado: (2022) -
Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand?
por: Esposito, Renata, et al.
Publicado: (2022) -
The History, Efficacy, and Safety of Potential Therapeutics: A Narrative Overview of the Complex Life of COVID-19
por: Daou, Farah, et al.
Publicado: (2021)